Phalloin is a solid exogenous compound with the chemical formula C35H48N8O10S. Phalloin belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 772.87 g/mol, Phalloin is a heavy molecule.
This compound targets four proteins: cytoplasmic 1 actin (ACTB), cytoplasmic 2 actin (ACTG1), alpha skeletal muscle actin (ACTA1), and aortic smooth muscle actin (ACTA2). Phallotoxins bind actin at the interface between F-actin subunits, locking adjacent subunits together and preventing depolymerization, which poisons the cell. This mechanism leads to a decrease in the rate constant for the dissociation of actin subunits from filament ends, essentially stabilizing actin filaments. Additionally, these toxins inhibit the ATP hydrolysis activity of F-actin. Phalloin is one of a group of toxins known as phallotoxins isolated from the death cap (Amanita phalloides). The phallotoxins consist of at least seven compounds, all of which have seven similar peptide rings.
belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds.
Oral, dermal, inhalation, and parenteral (contaminated drugs). (3)
Mechanism of Toxicity
Phallotoxins bind actin, preventing its depolymerization and poisoning the cell. They bind specifically at the interface between F-actin subunits, locking adjacent subunits together. This leads to a decrease in the rate constant for the dissociation of actin subunits from filament ends, which essentially stabilizes actin filaments through the prevention of filament depolymerization. Moreover, they inhibit the ATP hydrolysis activity of F-actin. (6, 2)
No indication of carcinogenicity to humans (not listed by IARC).
Uses/Sources
Prophalloin is one of a group of toxins from the death cap (Amanita phalloides) known as phallotoxins. (4)
Minimum Risk Level
Not Available
Health Effects
Liver lesions, tachycardia, hypoglycemia, hypotension and electrolyte imbalance with acid- base disturbance (5).
Symptoms
Hypovolemic shock; Gastrointestinal symptoms occur after a latent period and include abdominal pain, vomiting, and watery diarrhea. Neurologic symptoms are related to hepatic failure and may include encephalopathy, somnolence, confusion, coma and seizures (5).
Treatment
Consider gastric lavage and activated charcoal. (1)
